• Skip to main content
  • Skip to header right navigation
  • Skip to site footer
SPRINT® PNS System

SPR Therapeutics

SPRINT PNS System

  • Product
  • For Physicians
    • Clinical Outcomes & References
    • Implant Procedure Videos
    • PNS Leadership Learning Series
    • Fellows Learning Series
    • Video Resources
    • SPRcare Reimbursement
    • Important Safety Information
  • For Patients
    • Patient Stories
    • Patient Resources
    • Find a Physician
    • MicroLead™ Safety
  • About Us
  • News & Events
    • News
    • Events
    • Press Room
  • Careers
  • Contact Us

Peter Staats MD, MBA, DABA, ABIPP, FIPP

Peter Staats

Peter Staats MD, MBA, DABA, ABIPP, FIPP

Chief Medical Advisor

Dr. Staats was the founder of the division of Pain Medicine in the Department of Anesthesiology and Critical Care Medicine at Johns Hopkins University, where he was the division chief and director for over a decade.  In this capacity he was youngest major division chief in the history of Johns Hopkins Hospital and was the first anesthesiologist to obtain surgical at any academic university. In 2003 he became a founding partner in Premier Pain Centers in New Jersey which merged with National Spine and Pain Centers (NSPC), the largest pain practice in the United States.  He is currently the chief medical officer of both NSPC and electroCore.  He serves on the United States Health and Human Services Pain task force subcommittee whose mandate is to define appropriate treatment societies for pain in America.

He is boarded by the American Society of Anesthesiology, the American Board of Interventional Pain Physicians (ABIPP) and the World Institute of Pain (FIPP.   He has edited or co- authored 11 textbooks on pain medicine and written approximately four hundred articles, book chapters and abstracts on neuromodulation and the diagnosis and management of complex pain problems.  His publications have appeared in prominent journals including JAMA, Lancet, Anesthesiology, Pain Medicine and others.  He has chaired hundreds of meetings devoted to pain and neuromodulation around the world.

He is listed in Americas Top Doctors, New Jersey Top Doctors and Best Doctors in America. He is the Past President of (ASIPP), The American Society of Interventional Pain Physicians, the North American Neuromodulation Society (NANS), the southern pain society the New Jersey Society of interventional pain physicians (NJSIPP), and was the first chair of the American Society of Anesthesia’s committee on Interventional pain.  He is currently chairman of the Board of Examination World Institute of Pain (WIP) and is on the Executive Board of the WIP.   He is also the recipient of the President’s Distinguished Service Award and the Excellence in Pain Management Award from the Southern Pain Society, as well as the Physician of the Year Award from both the West Virginia Society of Interventional Pain and the New York and New Jersey Societies of Interventional Pain.   He has received distinguished service awards from AAPM, ASIPP, NANS and NJSIPP, and the Raj award for excellence (2017) and the lifetime achievement award (2018) from the American Society of Interventional Pain Physicians  and the (2018) lifetime achievement award from the West Virginia society of Interventional Pain Physicians WVSIPP and the lifetime achievement award (2018) from the NY and NJ Societies of interventional pain for contributions to the field of pain and neuromodulation and the lifetime achievement award from the North American Neuromodulation Society ( NANS ) 2019.

He is the recipient or co-recipient of numerous grants on the multiple facets of pain management.  His research in cancer pain demonstrated how good pain management could lessen side effects and improve life expectancy. He was the co-principle investigator on the largest randomized controlled trial ever performed on intrathecal pumps, and principle investigator on the first large scale trial on a novel intrathecal agent for pain.   His patents and research have led to novel approaches and FDA approvals in pain management and healthcare including novel pharmaceuticals and medical devices (Qutenza, Prialt and Gammacore).

His research on pain, mechanisms of placebo response, his unified theory of pain termed Psychological Behaviorism theory of pain, and interventional therapies have been highlighted on Good Morning America, Peter Jennings World News Tonight, CBS News, BBC and multiple newspapers including USA Today, the Washington Post Newsweek, Pain Medicine News and the Wallstreet Journal.

In addition to clinical and scientific work, his foundation, Positive outcomes worldwide is devoted to improving care around the world through education and training for pain and its treatment.

Our Team

Ben Austin, CPA

Ben Austin, CPA

David Youngberg

David Youngberg

Geoffrey Thrope

Geoffrey B. Thrope

Joseph Boggs

Joseph Boggs Ph.D

Maria Bennett

Maria E. Bennett

Mark Stultz

Mark Stultz

Michael Chuisano

Michael P. Chuisano

Nicolas Valeriani

Nicholas J. Valeriani

Robert Blankenship

Robert M. Blankenship

Warren Grill

Warren Grill Ph.D

SPRINT® PNS System

22901 Millcreek Blvd, Suite 110
Cleveland, OH 44122
(844) 378-9108 Phone
(216) 803-0777 Fax

Quick Links

  • Product
  • For Physicians
  • For Patients
  • About Us
  • News & Events
  • Careers
  • Contact Us

Info Links

  • Important Safety Information
  • Compliance
  • FCOI Policy
  • COVID-19 Response

Recent News Headlines

The Impact of COVID-19 on Chronic Pain and Stress: A Discussion with Dr. Mehul Desai

Could 60-Day Percutaneous PNS Treatment Lead to Sustained Pain Relief by Reconditioning the CNS?

WAPMU-SPRINT PNS System Training Lab

SPRINT PNS System Regional Training Lab – Salt Lake City

SPR Therapeutics

The SPRINT PNS System is indicated for up to 60 days in the back and/or extremities for: (i) Symptomatic relief of chronic, intractable pain, post-surgical and post-traumatic acute pain; (ii) Symptomatic relief of post-traumatic pain; and (iii) Symptomatic relief of post-operative pain. The SPRINT PNS System is not intended to treat pain in the craniofacial region. Physicians should use their best judgment when deciding when to use the SPRINT PNS System. For more information see the SPRINT PNS System IFU. Most common adverse events are skin irritation and erythema. Results may vary. Rx only.

View References for support of all claims.

The SPRINT® PNS System, MicroLead™, OnePass Introducer™, Rethink Your Pain Strategy™, Outsmart Pain™, Sustained Pain Relief Starts Here™, Life. Get Back to It.™ and SPR® are registered or common law trademarks of SPR Therapeutics, Inc.

Copyright © 2021 SPR Therapeutics. All Rights Reserved. | Privacy & Terms of Use | Patent Information | Product Terms & Conditions